1 asset in Prostate Intraepithelial Neoplasia

Therapeutic assets addressing Prostate Intraepithelial Neoplasia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
9-valent human papillomavirus recombinant vaccine Prostate Intraepithelial Neoplasia	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)